The Rationale for “Laser-Induced Thermal Therapy (LITT) and Intratumoral Cisplatin” Approach for Cancer Treatment
Authors:
- Renan Vieira de BritoRenan Vieira de Brito
- Marília Wellichan ManciniMMMarília Wellichan Mancini
- Marcel das Neves PalumboMPMarcel das Neves Palumbo
- Luis Henrique Oliveira de MoraesLMLuis Henrique Oliveira de Moraes
- Gerson Jhonatan RodriguesGRGerson Jhonatan Rodrigues
- Onivaldo CervantesOCOnivaldo Cervantes
- Joel Avram SercarzJSJoel Avram Sercarz
- Marcos Bandiera PaivaMPMarcos Bandiera Paiva
Open Access
- 25 May 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (11) , 5934
Abstract
Cisplatin is one of the most widely used anticancer drugs in the treatment of various types of solid human cancers, as well as germ cell tumors, sarcomas, and lymphomas. Strong evidence from research has demonstrated higher efficacy of a combination of cisplatin and derivatives, together with hyperthermia and light, in overcoming drug resistance and improving tumoricidal efficacy. It is well known that the antioncogenic potential of CDDP is markedly enhanced by hyperthermia compared to drug treatment alone. However, more recently, accelerators of high energy particles, such as synchrotrons, have been used to produce powerful and monochromatizable radiation to induce an Auger electron cascade in cis-platinum molecules. This is the concept that makes photoactivation of cis-platinum theoretically possible. Both heat and light increase cisplatin anticancer activity via multiple mechanisms, generating DNA lesions by interacting with purine bases in DNA followed by activation of several signal transduction pathways which finally lead to apoptosis. For the past twenty-seven years, our group has developed infrared photo-thermal activation of cisplatin for cancer treatment from bench to bedside. The future development of photoactivatable prodrugs of platinum-based agents injected intratumorally will increase selectivity, lower toxicity and increase efficacy of this important class of antitumor drugs, particularly when treating tumors accessible to laser-based fiber-optic devices, as in head and neck cancer. In this article, the mechanistic rationale of combined intratumor injections of cisplatin and laser-induced thermal therapy (CDDP–LITT) and the clinical application of such minimally invasive treatment for cancer are reviewed.Keywords
Funding Information
- National Institutes of Health (NIH/U01-CA065053-03, NIH/K23-CA088921-02, NIH/K22-CA131509-01, 1997/13043-5, 2008/54714-6)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (NIH/U01-CA065053-03, NIH/K23-CA088921-02, NIH/K22-CA131509-01, 1997/13043-5, 2008/54714-6)
This publication has 226 references indexed in Scilit:
- Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: A platform for near-infrared light-trigged drug releaseJournal of Controlled Release, 2012
- Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapyLung Cancer, 2012
- The role of the N-terminus of mammalian copper transporter 1 in the cellular accumulation of cisplatinBiochemical Pharmacology, 2010
- Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicineDalton Transactions, 2009
- The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicityAmerican Journal of Physiology-Renal Physiology, 2009
- A potent cytotoxic photoactivated platinum complexProceedings of the National Academy of Sciences, 2007
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Photodynamic therapy and anti-tumour immunityNature Reviews Cancer, 2006
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitationBiochemistry, 1985